newsfilter
← Latest News
PR Newswire·

Valeo Pharma's anti-blood clotting medication is now covered by public insurance in Ontario - proving fast-track to market model

VANCOUVER, BC, April 29, 2021 /PRNewswire/ - Valeo Pharma (CSE:VPH) (OTCQB:VPHIF) (FSE: VP2) has reached an agreement with the Ontario Public Drug Program to cover the costs of Redesca® and Redesca HP® – anticoagulants that reduce the risks of blood